Cosmos Week
De‑extinction company says it's made an artificial egg—if true, it could help save living species
BiologyEnglish editionScience journalismJournalistic coverage

De‑extinction company says it's made an artificial egg—if true, it could help save living species

Today's announcement by Texas-based de-extinction company Colossal Biosciences about a successful hatching of chicks from an artificial egg would represent a major innovation, if.

Original source cited and editorially framed by Cosmos Week. Phys. org Biology
Editorial signatureCosmos Week Editorial Desk
Published23 May 2026 13: 30 UTC
Updated2026-05-23
Coverage typeScience journalism
Evidence levelJournalistic coverage
Read time4 min read

Key points

  • Focus: Today's announcement by Texas-based de-extinction company Colossal Biosciences about a successful hatching of chicks from an artificial egg would
  • Detail: Science reporting: verify primary technical documentation
  • Editorial reading: science reporting; whenever possible, verify the cited primary source.
Full story

Today's announcement by Texas-based de-extinction company Colossal Biosciences about a successful hatching of chicks from an artificial egg would represent a major innovation, if the claims can be verified. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

This matters because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. This article has been reviewed according to Science X's editorial process and policies. Colossal's artificial egg could be groundbreaking science and deliver a useful tool for conservation.

Artificial egg technology, which involves transferring and growing a developing chick embryo outside a natural eggshell, has been around since the 1980s. Its version is based on the key innovations of an open, latticed half-shell and a transparent, silicone-based membrane that allows oxygen to freely diffuse from the air into the.

Embryo development would be observed directly through the transparent membrane, as in other artificial systems. Colossal is planning to genetically modify an emu genome to look more like that of a moa (as they did with gray wolves and dire wolves), create an embryo inside an emu egg, and.

Given the large size differences between chicken eggs and emu (up to 12 times bigger) and giant moa (up to 80 times bigger), there is not enough yolk and egg white in any living. A lot happens in an egg and only time will tell whether this new technology reflects natural processes and produces healthy individuals.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

But as our work on other extinct species shows, there is also widespread Māori and public opposition in New Zealand to the company's plans to "de-extinct" the moa for an. Discover the latest in science, tech, and space with over 100, 000 subscribers who rely on Phys. org for daily insights.

Because this item comes through Phys. org Biology as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source